< Back to Press Releases

Monthly Archives: November 2018

Healthy? Stay fit to avoid a heart attack

Even if you are a fit and healthy person with no signs of any heart or blood vessel disease, low cardiorespiratory fitness could be a warning sign of future problems, according to a study published in the European Heart Journal … Continue reading

Published Thursday, November 29th, 2018 at 12:05 am
Posted in Cardiology

Endurance but not resistance training has anti-aging effects

Researchers have discovered evidence that endurance exercise, such as running, swimming, cross-country skiing and cycling, will help you age better than resistance exercise, which involves strength training with weights. In a study published in the European Heart Journal [1], researchers … Continue reading

Published Wednesday, November 28th, 2018 at 12:05 am
Posted in Cardiology, Genetics

Exposure to e-cigarette adverts linked to teenagers using e-cigarettes and smoking

The more often adolescents say they have seen adverts for e-cigarettes, the more often they use both e-cigarettes and smoke tobacco cigarettes, according to a study published in ERJ Open Research. The study took place in Germany, where regulations around … Continue reading

Published Wednesday, November 28th, 2018 at 12:01 am
Posted in Respiratory

Residual inflammation risk affects outcomes in patients after percutaneous coronary intervention

Patients who have persistently high levels of inflammation following percutaneous coronary intervention (PCI) for coronary artery disease are significantly more likely to die from any cause or to have a heart attack within a year, according to a study of … Continue reading

Published Monday, November 19th, 2018 at 12:05 am
Posted in Cardiology

Bullying and violence at work increases the risk of cardiovascular disease

People who are bullied at work or experience violence at work are at higher risk of heart and brain blood vessel problems, including heart attacks and stroke, according to the largest prospective study to investigate the link, which is published … Continue reading

Published Monday, November 19th, 2018 at 12:05 am
Posted in Cardiology

Patients with rare, incurable digestive tract cancers respond to new drug combination

Dublin, Ireland: Patients with rare, but incurable cancers of the digestive tract have responded well to a combination of two drugs that block the MEK and BRAF pathways, which drive the disease in some cases. They have survived for longer … Continue reading

Published Friday, November 16th, 2018 at 12:01 am
Posted in Cancer

Difficult-to-treat bowel cancers respond in first study of new drug combination

Dublin, Ireland: Early results from a phase I trial in a small group of patients with advanced cancer using two drugs (nivolumab and pixatimod) that stimulate the immune system report that patients with bowel cancer may benefit from the combination. … Continue reading

Published Thursday, November 15th, 2018 at 12:01 am
Posted in Cancer

Combination of two immunotherapies shows activity in non-small cell lung cancer patients

Dublin, Ireland: A combination of two drugs, which prompt the body’s immune system to identify and kill cancer cells, is a safe treatment for patients with advanced non-small cell lung cancer and has shown some signs of efficacy. Results from … Continue reading

Published Thursday, November 15th, 2018 at 12:01 am
Posted in Cancer

Drug combination makes cancer disappear in mice with neuroblastoma: ‘significant’ findings suggest potential for effective, non-toxic treatment for this aggressive childhood cancer

Dublin, Ireland: Researchers investigating new treatments for neuroblastoma – one of the most common childhood cancers – have found that a combination of two drugs made tumours disappear in mice, making it more effective than any other drugs tested in … Continue reading

Published Thursday, November 15th, 2018 at 12:01 am
Posted in Cancer

Two genomic tests identify groups of patients most likely to benefit from new drugs: latest results from I-SPY 2 trial

Dublin, Ireland: New results from a long-running trial to identify which new drugs or combinations of drugs are most effective in which types of breast cancer, show that two genomic tests are bringing the era of truly personalised medicine ever … Continue reading

Published Wednesday, November 14th, 2018 at 2:30 pm
Posted in Cancer, Genetics
.